What does CCCP mean in CANCER

The CCCP is designed to test a wide range of solid tumors, including breast, lung, colorectal, endometrial, melanoma, and prostate cancer. It can also be used to test for rare cancers or to guide treatment decisions for patients with metastatic disease.

The CCCP test is performed on a tumor biopsy sample obtained through a procedure such as a biopsy or surgery. The sample is analyzed using next-generation sequencing (NGS) technology, which allows for the simultaneous sequencing of multiple genes.

The CCCP report provides detailed information on:

• Mutations in genes known to be involved in cancer
• Copy number alterations (gains or losses of genetic material)
• Gene fusions and other genomic rearrangements
• Tumor mutational burden (TMB) and microsatellite instability (MSI) status, which can influence treatment options

The CCCP results can help oncologists identify the most appropriate treatment options for each patient. For example, the test can identify mutations that make the tumor more likely to respond to certain targeted therapies or immunotherapies. It can also help identify patients who may be candidates for clinical trials.

While the CCCP test is comprehensive, it does have some limitations. The test may not be able to detect all genomic alterations in a tumor, and it is important to note that not all alterations identified by the test will be actionable. Additionally, the test results may not be immediately available and may take several weeks to process.